Accessibility Menu
 
Resverlogix logo

Resverlogix

(OTC) RVXCF

Current Price$0.08
Market Cap$24.22M
Since IPO (2012)-96%
5 Year-90%
1 Year+158%
1 Month-2%

Resverlogix Financials at a Glance

Market Cap

$24.22M

Revenue (TTM)

$0.00

Net Income (TTM)

$7.76M

EPS (TTM)

$-0.03

P/E Ratio

-2.80

Dividend

$0.00

Beta (Volatility)

0.53 (Low)

Price

$0.08

Volume

83

Open

$0.07

Previous Close

$0.08

Daily Range

$0.07 - $0.08

52-Week Range

$0.03 - $0.21

RVXCF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Resverlogix

Industry

Biotechnology

Employees

18

CEO

Donald J. McCaffrey

Headquarters

Calgary, AB T3E 6L1, CA

RVXCF Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

14%

Return on Assets

-1%

Earnings Yield

-35.71%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$24.22M

Shares Outstanding

316.17M

Volume

83

Avg. Volume

9.25K

Financials (TTM)

Gross Profit

$437.53K

Operating Income

$5.20M

EBITDA

$4.77M

Operating Cash Flow

$3.73M

Capital Expenditure

$9.16K

Free Cash Flow

$3.73M

Cash & ST Invst.

$107.80K

Total Debt

$72.77M

Resverlogix Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$120.28K

-37.5%

Gross Margin

0.00%

N/A

Market Cap

$24.22M

N/A

Market Cap/Employee

$1.27M

N/A

Employees

19

N/A

Net Income

$209.17K

-144.8%

EBITDA

$348.00K

+127.2%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$72.66M

-3.6%

Accounts Receivable

$910.34K

+277.7%

Inventory

$434.21K

-56.4%

Long Term Debt

$52.01M

-16.0%

Short Term Debt

$20.76M

+149.0%

Return on Assets

-1.02%

N/A

Return on Invested Capital

14.19%

N/A

Free Cash Flow

$1.04M

+3.0%

Operating Cash Flow

$1.03M

-3.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MEDIFMediPharm Labs Corp.
$0.07+5.60%
CLYYFCelyad Oncology S.A.
$0.25+0.00%
CLCSCell Source, Inc.
$0.84+2.74%
FNCHFinch Therapeutics Group, Inc.
$6.21-4.02%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$99.62+0.05%
NOKNokia
$13.30+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%

Questions About RVXCF

What is the current price of Resverlogix?

Resverlogix is trading at $0.08 per share.

What is the 52-week range for Resverlogix?

Over the past 52 weeks, Resverlogix has traded between $0.03 and $0.21.

How much debt does Resverlogix have?

As of the most recent reporting period, Resverlogix reported total debt of $72.90M.

How much cash does Resverlogix have on hand?

Resverlogix reported $108,000 in cash and cash equivalents in its most recent financial results.

What is Resverlogix’s dividend yield?

Resverlogix does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.